In esophageal squamous cell carcinoma, p53-induced GBP2 upregulation signals poor survival, highlighting its oncogenic potential in specific TME contexts, driven by cooperation with interferon regulatory factor 1 (IRF-1) [44]. The gene discussed is IRF1; the disease is esophageal squamous cell carcinoma.